aluates Reports

$ 0.0

Automative

Global HPV Vaccine for Men(Male HPV Vaccine) Market Research Report 2026

Published Date: 2026-01-20

Report Code: QYRE-Auto-26I18410

Global HPV Vaccine for Men Male HPV Vaccine Market Research Report 2024

BUY CHAPTERS

Global HPV Vaccine for Men(Male HPV Vaccine) Market Research Report 2026

Code: QYRE-Auto-26I18410

Report

2026-01-20

Pages:92

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Merck

Wantai Biotech

Kangle Guardian

Bovaxbio

HPV Vaccine for Men(Male HPV Vaccine) Market Size

The global HPV Vaccine for Men(Male HPV Vaccine) market was valued at US$ 23.41 million in 2025 and is anticipated to reach US$ 37.58 million by 2032, at a CAGR of 7.1% from 2026 to 2032.

HPV Vaccine for Men(Male HPV Vaccine) Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on HPV Vaccine for Men(Male HPV Vaccine) competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Male HPV vaccine refers to the HPV vaccine developed specifically for men. HPV (human papillomavirus) is a virus that can infect the skin and mucous membranes, and is divided into low-risk and high-risk types. Low-risk HPV infection may cause skin lesions such as genital warts, while high-risk HPV infection is associated with an increased risk of malignant tumors such as penile cancer, anal cancer, and oral cancer. Therefore, HPV vaccination for men is of great significance in preventing these diseases, which can not only prevent related diseases but also reduce the risk of transmission.

The North American market for HPV Vaccine for Men(Male HPV Vaccine) is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for HPV Vaccine for Men(Male HPV Vaccine) is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

Major global manufacturers of HPV Vaccine for Men(Male HPV Vaccine) include Merck, Wantai Biotech, Kangle Guardian, Bovaxbio, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global HPV Vaccine for Men(Male HPV Vaccine) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding HPV Vaccine for Men(Male HPV Vaccine). The HPV Vaccine for Men(Male HPV Vaccine) market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global HPV Vaccine for Men(Male HPV Vaccine) market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist HPV Vaccine for Men(Male HPV Vaccine) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of HPV Vaccine for Men(Male HPV Vaccine) Market Report

Report Metric	Details
Report Name	HPV Vaccine for Men(Male HPV Vaccine) Market
Accounted market size in 2025	US$ 23.41 million
Forecasted market size in 2032	US$ 37.58 million
CAGR	7.1%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Domestic Imported
by Application	Genital Warts Penile Cancer and Precancerous Lesions Perineal Cancer and Precancerous Lesions Perianal Cancer and Precancerous Lesions Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Merck, Wantai Biotech, Kangle Guardian, Bovaxbio
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for HPV Vaccine for Men(Male HPV Vaccine) manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines HPV Vaccine for Men(Male HPV Vaccine) sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is HPV Vaccine for Men(Male HPV Vaccine) Market growing?

Ans: The HPV Vaccine for Men(Male HPV Vaccine) Market witnessing a CAGR of 7.1% during the forecast period 2026-2032.

What is the HPV Vaccine for Men(Male HPV Vaccine) Market size in 2032?

Ans: The HPV Vaccine for Men(Male HPV Vaccine) Market size in 2032 will be US$ 37.58 million.

Who are the main players in the HPV Vaccine for Men(Male HPV Vaccine) Market report?

Ans: The main players in the HPV Vaccine for Men(Male HPV Vaccine) Market are Merck, Wantai Biotech, Kangle Guardian, Bovaxbio

What are the Application segmentation covered in the HPV Vaccine for Men(Male HPV Vaccine) Market report?

Ans: The Applications covered in the HPV Vaccine for Men(Male HPV Vaccine) Market report are Genital Warts, Penile Cancer and Precancerous Lesions, Perineal Cancer and Precancerous Lesions, Perianal Cancer and Precancerous Lesions, Others

What are the Type segmentation covered in the HPV Vaccine for Men(Male HPV Vaccine) Market report?

Ans: The Types covered in the HPV Vaccine for Men(Male HPV Vaccine) Market report are Domestic, Imported

1 HPV Vaccine for Men(Male HPV Vaccine) Market Overview

1.1 Product Definition

1.2 HPV Vaccine for Men(Male HPV Vaccine) by Type

1.2.1 Global HPV Vaccine for Men(Male HPV Vaccine) Market Value by Type: 2025 vs 2032

1.2.2 Domestic

1.2.3 Imported

1.3 HPV Vaccine for Men(Male HPV Vaccine) by Application

1.3.1 Global HPV Vaccine for Men(Male HPV Vaccine) Market Value by Application: 2025 vs 2032

1.3.2 Genital Warts

1.3.3 Penile Cancer and Precancerous Lesions

1.3.4 Perineal Cancer and Precancerous Lesions

1.3.5 Perianal Cancer and Precancerous Lesions

1.3.6 Others

1.4 Global HPV Vaccine for Men(Male HPV Vaccine) Market Size Estimates and Forecasts

1.4.1 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue 2021–2032

1.4.2 Global HPV Vaccine for Men(Male HPV Vaccine) Sales 2021–2032

1.4.3 Global HPV Vaccine for Men(Male HPV Vaccine) Market Average Price (2021–2032)

1.5 Assumptions and Limitations

2 HPV Vaccine for Men(Male HPV Vaccine) Market Competition by Manufacturers

2.1 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Market Share by Manufacturers (2021–2026)

2.2 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue Market Share by Manufacturers (2021–2026)

2.3 Global HPV Vaccine for Men(Male HPV Vaccine) Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of HPV Vaccine for Men(Male HPV Vaccine), Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of HPV Vaccine for Men(Male HPV Vaccine), Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of HPV Vaccine for Men(Male HPV Vaccine), Product Types and Applications

2.7 Global Key Manufacturers of HPV Vaccine for Men(Male HPV Vaccine), Date of Entry into the Industry

2.8 Global HPV Vaccine for Men(Male HPV Vaccine) Market Competitive Situation and Trends

2.8.1 Global HPV Vaccine for Men(Male HPV Vaccine) Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global HPV Vaccine for Men(Male HPV Vaccine) Players Market Share by Revenue

2.8.3 Global HPV Vaccine for Men(Male HPV Vaccine) Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global HPV Vaccine for Men(Male HPV Vaccine) Market Scenario by Region

3.1 Global HPV Vaccine for Men(Male HPV Vaccine) Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Region: 2021–2032

3.2.1 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Region: 2021–2026

3.2.2 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Region: 2027–2032

3.3 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Region: 2021–2032

3.3.1 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Region: 2021–2026

3.3.2 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Region: 2027–2032

3.4 North America HPV Vaccine for Men(Male HPV Vaccine) Market Facts & Figures by Country

3.4.1 North America HPV Vaccine for Men(Male HPV Vaccine) Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America HPV Vaccine for Men(Male HPV Vaccine) Sales by Country (2021–2032)

3.4.3 North America HPV Vaccine for Men(Male HPV Vaccine) Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe HPV Vaccine for Men(Male HPV Vaccine) Market Facts & Figures by Country

3.5.1 Europe HPV Vaccine for Men(Male HPV Vaccine) Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe HPV Vaccine for Men(Male HPV Vaccine) Sales by Country (2021–2032)

3.5.3 Europe HPV Vaccine for Men(Male HPV Vaccine) Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific HPV Vaccine for Men(Male HPV Vaccine) Market Facts & Figures by Region

3.6.1 Asia Pacific HPV Vaccine for Men(Male HPV Vaccine) Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific HPV Vaccine for Men(Male HPV Vaccine) Sales by Region (2021–2032)

3.6.3 Asia Pacific HPV Vaccine for Men(Male HPV Vaccine) Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America HPV Vaccine for Men(Male HPV Vaccine) Market Facts & Figures by Country

3.7.1 Latin America HPV Vaccine for Men(Male HPV Vaccine) Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America HPV Vaccine for Men(Male HPV Vaccine) Sales by Country (2021–2032)

3.7.3 Latin America HPV Vaccine for Men(Male HPV Vaccine) Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa HPV Vaccine for Men(Male HPV Vaccine) Market Facts & Figures by Country

3.8.1 Middle East and Africa HPV Vaccine for Men(Male HPV Vaccine) Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa HPV Vaccine for Men(Male HPV Vaccine) Sales by Country (2021–2032)

3.8.3 Middle East and Africa HPV Vaccine for Men(Male HPV Vaccine) Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Type (2021–2032)

4.1.1 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Type (2021–2026)

4.1.2 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Type (2027–2032)

4.1.3 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Market Share by Type (2021–2032)

4.2 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Type (2021–2032)

4.2.1 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Type (2021–2026)

4.2.2 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Type (2027–2032)

4.2.3 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue Market Share by Type (2021–2032)

4.3 Global HPV Vaccine for Men(Male HPV Vaccine) Price by Type (2021–2032)

5 Segment by Application

5.1 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Application (2021–2032)

5.1.1 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Application (2021–2026)

5.1.2 Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Application (2027–2032)

5.1.3 Global HPV Vaccine for Men(Male HPV Vaccine) Sales Market Share by Application (2021–2032)

5.2 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Application (2021–2032)

5.2.1 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Application (2021–2026)

5.2.2 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Application (2027–2032)

5.2.3 Global HPV Vaccine for Men(Male HPV Vaccine) Revenue Market Share by Application (2021–2032)

5.3 Global HPV Vaccine for Men(Male HPV Vaccine) Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Merck

6.1.1 Merck Company Information

6.1.2 Merck Description and Business Overview

6.1.3 Merck HPV Vaccine for Men(Male HPV Vaccine) Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Merck HPV Vaccine for Men(Male HPV Vaccine) Product Portfolio

6.1.5 Merck Recent Developments/Updates

6.2 Wantai Biotech

6.2.1 Wantai Biotech Company Information

6.2.2 Wantai Biotech Description and Business Overview

6.2.3 Wantai Biotech HPV Vaccine for Men(Male HPV Vaccine) Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Wantai Biotech HPV Vaccine for Men(Male HPV Vaccine) Product Portfolio

6.2.5 Wantai Biotech Recent Developments/Updates

6.3 Kangle Guardian

6.3.1 Kangle Guardian Company Information

6.3.2 Kangle Guardian Description and Business Overview

6.3.3 Kangle Guardian HPV Vaccine for Men(Male HPV Vaccine) Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Kangle Guardian HPV Vaccine for Men(Male HPV Vaccine) Product Portfolio

6.3.5 Kangle Guardian Recent Developments/Updates

6.4 Bovaxbio

6.4.1 Bovaxbio Company Information

6.4.2 Bovaxbio Description and Business Overview

6.4.3 Bovaxbio HPV Vaccine for Men(Male HPV Vaccine) Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Bovaxbio HPV Vaccine for Men(Male HPV Vaccine) Product Portfolio

6.4.5 Bovaxbio Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 HPV Vaccine for Men(Male HPV Vaccine) Industry Chain Analysis

7.2 HPV Vaccine for Men(Male HPV Vaccine) Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 HPV Vaccine for Men(Male HPV Vaccine) Production Mode & Process Analysis

7.4 HPV Vaccine for Men(Male HPV Vaccine) Sales and Marketing

7.4.1 HPV Vaccine for Men(Male HPV Vaccine) Sales Channels

7.4.2 HPV Vaccine for Men(Male HPV Vaccine) Distributors

7.5 HPV Vaccine for Men(Male HPV Vaccine) Customer Analysis

8 HPV Vaccine for Men(Male HPV Vaccine) Market Dynamics

8.1 HPV Vaccine for Men(Male HPV Vaccine) Industry Trends

8.2 HPV Vaccine for Men(Male HPV Vaccine) Market Drivers

8.3 HPV Vaccine for Men(Male HPV Vaccine) Market Challenges

8.4 HPV Vaccine for Men(Male HPV Vaccine) Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Merck

Wantai Biotech

Kangle Guardian

Bovaxbio

List of Tables

Table 1. Global HPV Vaccine for Men(Male HPV Vaccine) Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global HPV Vaccine for Men(Male HPV Vaccine) Market Value by Application (US$ Million), 2025 vs 2032

Table 3. Global HPV Vaccine for Men(Male HPV Vaccine) Market Competitive Situation by Manufacturers in 2025

Table 4. Global HPV Vaccine for Men(Male HPV Vaccine) Sales (K Units) of Key Manufacturers (2021–2026)

Table 5. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Market Share by Manufacturers (2021–2026)

Table 6. Global HPV Vaccine for Men(Male HPV Vaccine) Revenue (US$ Million) by Manufacturers (2021–2026)

Table 7. Global HPV Vaccine for Men(Male HPV Vaccine) Revenue Share by Manufacturers (2021–2026)

Table 8. Global Market HPV Vaccine for Men(Male HPV Vaccine) Average Price (US$/Unit) of Key Manufacturers (2021–2026)

Table 9. Global Key Players of HPV Vaccine for Men(Male HPV Vaccine), Industry Ranking, 2023 vs 2024 vs 2025

Table 10. Global Key Manufacturers of HPV Vaccine for Men(Male HPV Vaccine), Manufacturing Sites and Headquarters

Table 11. Global Key Manufacturers of HPV Vaccine for Men(Male HPV Vaccine), Product Types and Applications

Table 12. Global Key Manufacturers of HPV Vaccine for Men(Male HPV Vaccine), Date of Entry into the Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global HPV Vaccine for Men(Male HPV Vaccine) Companies by Tier (Tier 1, Tier 2, Tier 3), based on HPV Vaccine for Men(Male HPV Vaccine) Revenue, 2025

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global HPV Vaccine for Men(Male HPV Vaccine) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 17. Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Region (K Units), 2021–2026

Table 18. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Market Share by Region (2021–2026)

Table 19. Global HPV Vaccine for Men(Male HPV Vaccine) Sales by Region (K Units), 2027–2032

Table 20. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Market Share by Region (2027–2032)

Table 21. Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Region (US$ Million), 2021–2026

Table 22. Global HPV Vaccine for Men(Male HPV Vaccine) Revenue Market Share by Region (2021–2026)

Table 23. Global HPV Vaccine for Men(Male HPV Vaccine) Revenue by Region (US$ Million), 2027–2032

Table 24. Global HPV Vaccine for Men(Male HPV Vaccine) Revenue Market Share by Region (2027–2032)

Table 25. North America HPV Vaccine for Men(Male HPV Vaccine) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 26. North America HPV Vaccine for Men(Male HPV Vaccine) Sales by Country (K Units), 2021–2026

Table 27. North America HPV Vaccine for Men(Male HPV Vaccine) Sales by Country (K Units), 2027–2032

Table 28. North America HPV Vaccine for Men(Male HPV Vaccine) Revenue by Country (US$ Million), 2021–2026

Table 29. North America HPV Vaccine for Men(Male HPV Vaccine) Revenue by Country (US$ Million), 2027–2032

Table 30. Europe HPV Vaccine for Men(Male HPV Vaccine) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 31. Europe HPV Vaccine for Men(Male HPV Vaccine) Sales by Country (K Units), 2021–2026

Table 32. Europe HPV Vaccine for Men(Male HPV Vaccine) Sales by Country (K Units), 2027–2032

Table 33. Europe HPV Vaccine for Men(Male HPV Vaccine) Revenue by Country (US$ Million), 2021–2026

Table 34. Europe HPV Vaccine for Men(Male HPV Vaccine) Revenue by Country (US$ Million), 2027–2032

Table 35. Asia Pacific HPV Vaccine for Men(Male HPV Vaccine) Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 36. Asia Pacific HPV Vaccine for Men(Male HPV Vaccine) Sales by Region (K Units), 2021–2026

Table 37. Asia Pacific HPV Vaccine for Men(Male HPV Vaccine) Sales by Region (K Units), 2027–2032

Table 38. Asia Pacific HPV Vaccine for Men(Male HPV Vaccine) Revenue by Region (US$ Million), 2021–2026

Table 39. Asia Pacific HPV Vaccine for Men(Male HPV Vaccine) Revenue by Region (US$ Million), 2027–2032

Table 40. Latin America HPV Vaccine for Men(Male HPV Vaccine) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 41. Latin America HPV Vaccine for Men(Male HPV Vaccine) Sales by Country (K Units), 2021–2026

Table 42. Latin America HPV Vaccine for Men(Male HPV Vaccine) Sales by Country (K Units), 2027–2032

Table 43. Latin America HPV Vaccine for Men(Male HPV Vaccine) Revenue by Country (US$ Million), 2021–2026

Table 44. Latin America HPV Vaccine for Men(Male HPV Vaccine) Revenue by Country (US$ Million), 2027–2032

Table 45. Middle East and Africa HPV Vaccine for Men(Male HPV Vaccine) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 46. Middle East and Africa HPV Vaccine for Men(Male HPV Vaccine) Sales by Country (K Units), 2021–2026

Table 47. Middle East and Africa HPV Vaccine for Men(Male HPV Vaccine) Sales by Country (K Units), 2027–2032

Table 48. Middle East and Africa HPV Vaccine for Men(Male HPV Vaccine) Revenue by Country (US$ Million), 2021–2026

Table 49. Middle East and Africa HPV Vaccine for Men(Male HPV Vaccine) Revenue by Country (US$ Million), 2027–2032

Table 50. Global HPV Vaccine for Men(Male HPV Vaccine) Sales (K Units) by Type (2021–2026)

Table 51. Global HPV Vaccine for Men(Male HPV Vaccine) Sales (K Units) by Type (2027–2032)

Table 52. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Market Share by Type (2021–2026)

Table 53. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Market Share by Type (2027–2032)

Table 54. Global HPV Vaccine for Men(Male HPV Vaccine) Revenue (US$ Million) by Type (2021–2026)

Table 55. Global HPV Vaccine for Men(Male HPV Vaccine) Revenue (US$ Million) by Type (2027–2032)

Table 56. Global HPV Vaccine for Men(Male HPV Vaccine) Revenue Market Share by Type (2021–2026)

Table 57. Global HPV Vaccine for Men(Male HPV Vaccine) Revenue Market Share by Type (2027–2032)

Table 58. Global HPV Vaccine for Men(Male HPV Vaccine) Price (US$/Unit) by Type (2021–2026)

Table 59. Global HPV Vaccine for Men(Male HPV Vaccine) Price (US$/Unit) by Type (2027–2032)

Table 60. Global HPV Vaccine for Men(Male HPV Vaccine) Sales (K Units) by Application (2021–2026)

Table 61. Global HPV Vaccine for Men(Male HPV Vaccine) Sales (K Units) by Application (2027–2032)

Table 62. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Market Share by Application (2021–2026)

Table 63. Global HPV Vaccine for Men(Male HPV Vaccine) Sales Market Share by Application (2027–2032)

Table 64. Global HPV Vaccine for Men(Male HPV Vaccine) Revenue (US$ Million) by Application (2021–2026)

Table 65. Global HPV Vaccine for Men(Male HPV Vaccine) Revenue (US$ Million) by Application (2027–2032)

Table 66. Global HPV Vaccine for Men(Male HPV Vaccine) Revenue Market Share by Application (2021–2026)

Table 67. Global HPV Vaccine for Men(Male HPV Vaccine) Revenue Market Share by Application (2027–2032)

Table 68. Global HPV Vaccine for Men(Male HPV Vaccine) Price (US$/Unit) by Application (2021–2026)

Table 69. Global HPV Vaccine for Men(Male HPV Vaccine) Price (US$/Unit) by Application (2027–2032)

Table 70. Merck Company Information

Table 71. Merck Description and Business Overview

Table 72. Merck HPV Vaccine for Men(Male HPV Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 73. Merck HPV Vaccine for Men(Male HPV Vaccine) Product

Table 74. Merck Recent Developments/Updates

Table 75. Wantai Biotech Company Information

Table 76. Wantai Biotech Description and Business Overview

Table 77. Wantai Biotech HPV Vaccine for Men(Male HPV Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 78. Wantai Biotech HPV Vaccine for Men(Male HPV Vaccine) Product

Table 79. Wantai Biotech Recent Developments/Updates

Table 80. Kangle Guardian Company Information

Table 81. Kangle Guardian Description and Business Overview

Table 82. Kangle Guardian HPV Vaccine for Men(Male HPV Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 83. Kangle Guardian HPV Vaccine for Men(Male HPV Vaccine) Product

Table 84. Kangle Guardian Recent Developments/Updates

Table 85. Bovaxbio Company Information

Table 86. Bovaxbio Description and Business Overview

Table 87. Bovaxbio HPV Vaccine for Men(Male HPV Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 88. Bovaxbio HPV Vaccine for Men(Male HPV Vaccine) Product

Table 89. Bovaxbio Recent Developments/Updates

Table 90. Key Raw Materials Lists

Table 91. Raw Materials Key Suppliers Lists

Table 92. HPV Vaccine for Men(Male HPV Vaccine) Distributors List

Table 93. HPV Vaccine for Men(Male HPV Vaccine) Customers List

Table 94. HPV Vaccine for Men(Male HPV Vaccine) Market Trends

Table 95. HPV Vaccine for Men(Male HPV Vaccine) Market Drivers

Table 96. HPV Vaccine for Men(Male HPV Vaccine) Market Challenges

Table 97. HPV Vaccine for Men(Male HPV Vaccine) Market Restraints

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

Table 101. Authors List of This Report

List of Figures

Figure 1. Product Picture of HPV Vaccine for Men(Male HPV Vaccine)

Figure 2. Global HPV Vaccine for Men(Male HPV Vaccine) Market Value by Type (US$ Million), 2021–2032

Figure 3. Global HPV Vaccine for Men(Male HPV Vaccine) Market Share by Type: 2025 & 2032

Figure 4. Domestic Product Picture

Figure 5. Imported Product Picture

Figure 6. Global HPV Vaccine for Men(Male HPV Vaccine) Market Value by Application (US$ Million), 2021–2032

Figure 7. Global HPV Vaccine for Men(Male HPV Vaccine) Market Share by Application: 2025 & 2032

Figure 8. Genital Warts

Figure 9. Penile Cancer and Precancerous Lesions

Figure 10. Perineal Cancer and Precancerous Lesions

Figure 11. Perianal Cancer and Precancerous Lesions

Figure 12. Others

Figure 13. Global HPV Vaccine for Men(Male HPV Vaccine) Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 14. Global HPV Vaccine for Men(Male HPV Vaccine) Market Size (US$ Million), 2021–2032

Figure 15. Global HPV Vaccine for Men(Male HPV Vaccine) Sales (K Units), 2021–2032

Figure 16. Global HPV Vaccine for Men(Male HPV Vaccine) Average Price (US$/Unit), 2021–2032

Figure 17. HPV Vaccine for Men(Male HPV Vaccine) Report Years Considered

Figure 18. HPV Vaccine for Men(Male HPV Vaccine) Sales Share by Manufacturers in 2025

Figure 19. Global HPV Vaccine for Men(Male HPV Vaccine) Revenue Share by Manufacturers in 2025

Figure 20. Top 5 and Top 10 Global HPV Vaccine for Men(Male HPV Vaccine) Players: Market Share by Revenue in HPV Vaccine for Men(Male HPV Vaccine) in 2025

Figure 21. HPV Vaccine for Men(Male HPV Vaccine) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 22. Global HPV Vaccine for Men(Male HPV Vaccine) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 23. North America HPV Vaccine for Men(Male HPV Vaccine) Sales Market Share by Country (2021–2032)

Figure 24. North America HPV Vaccine for Men(Male HPV Vaccine) Revenue Market Share by Country (2021–2032)

Figure 25. United States HPV Vaccine for Men(Male HPV Vaccine) Revenue Growth Rate (US$ Million), 2021–2032

Figure 26. Canada HPV Vaccine for Men(Male HPV Vaccine) Revenue Growth Rate (US$ Million), 2021–2032

Figure 27. Europe HPV Vaccine for Men(Male HPV Vaccine) Sales Market Share by Country (2021–2032)

Figure 28. Europe HPV Vaccine for Men(Male HPV Vaccine) Revenue Market Share by Country (2021–2032)

Figure 29. Germany HPV Vaccine for Men(Male HPV Vaccine) Revenue Growth Rate (US$ Million), 2021–2032

Figure 30. France HPV Vaccine for Men(Male HPV Vaccine) Revenue Growth Rate (US$ Million), 2021–2032

Figure 31. U.K. HPV Vaccine for Men(Male HPV Vaccine) Revenue Growth Rate (US$ Million), 2021–2032

Figure 32. Italy HPV Vaccine for Men(Male HPV Vaccine) Revenue Growth Rate (US$ Million), 2021–2032

Figure 33. Russia HPV Vaccine for Men(Male HPV Vaccine) Revenue Growth Rate (US$ Million), 2021–2032

Figure 34. Asia Pacific HPV Vaccine for Men(Male HPV Vaccine) Sales Market Share by Region (2021–2032)

Figure 35. Asia Pacific HPV Vaccine for Men(Male HPV Vaccine) Revenue Market Share by Region (2021–2032)

Figure 36. China HPV Vaccine for Men(Male HPV Vaccine) Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. Japan HPV Vaccine for Men(Male HPV Vaccine) Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. South Korea HPV Vaccine for Men(Male HPV Vaccine) Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. India HPV Vaccine for Men(Male HPV Vaccine) Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. Australia HPV Vaccine for Men(Male HPV Vaccine) Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. China Taiwan HPV Vaccine for Men(Male HPV Vaccine) Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. Southeast Asia HPV Vaccine for Men(Male HPV Vaccine) Revenue Growth Rate (US$ Million), 2021–2032

Figure 43. Latin America HPV Vaccine for Men(Male HPV Vaccine) Sales Market Share by Country (2021–2032)

Figure 44. Latin America HPV Vaccine for Men(Male HPV Vaccine) Revenue Market Share by Country (2021–2032)

Figure 45. Mexico HPV Vaccine for Men(Male HPV Vaccine) Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. Brazil HPV Vaccine for Men(Male HPV Vaccine) Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. Argentina HPV Vaccine for Men(Male HPV Vaccine) Revenue Growth Rate (US$ Million), 2021–2032

Figure 48. Colombia HPV Vaccine for Men(Male HPV Vaccine) Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. Middle East and Africa HPV Vaccine for Men(Male HPV Vaccine) Sales Market Share by Country (2021–2032)

Figure 50. Middle East and Africa HPV Vaccine for Men(Male HPV Vaccine) Revenue Market Share by Country (2021–2032)

Figure 51. Turkey HPV Vaccine for Men(Male HPV Vaccine) Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. Saudi Arabia HPV Vaccine for Men(Male HPV Vaccine) Revenue Growth Rate (US$ Million), 2021–2032

Figure 53. UAE HPV Vaccine for Men(Male HPV Vaccine) Revenue Growth Rate (US$ Million), 2021–2032

Figure 54. Global Sales Market Share of HPV Vaccine for Men(Male HPV Vaccine) by Type (2021–2032)

Figure 55. Global Revenue Market Share of HPV Vaccine for Men(Male HPV Vaccine) by Type (2021–2032)

Figure 56. Global HPV Vaccine for Men(Male HPV Vaccine) Price (US$/Unit) by Type (2021–2032)

Figure 57. Global Sales Market Share of HPV Vaccine for Men(Male HPV Vaccine) by Application (2021–2032)

Figure 58. Global Revenue Market Share of HPV Vaccine for Men(Male HPV Vaccine) by Application (2021–2032)

Figure 59. Global HPV Vaccine for Men(Male HPV Vaccine) Price (US$/Unit) by Application (2021–2032)

Figure 60. HPV Vaccine for Men(Male HPV Vaccine) Value Chain

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Cervical Cancer Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Recombinant Human Papillomavirus 9 Valent Vaccine Market Research Report 2024

Bivalent HPV Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

HPV Therapeutic Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Gardasil HPV Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

HPV Quadrivalent Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Intramuscular HPV Vaccine Market Research Report 2024

4 valent HPV Vaccine 4vHPV Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global HPV Testing Market Insights Forecast to 2030

Human Papillomavirus Infection Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global HPV Test Reagent kit Market Research Report 2024

Global HPV DNA Test Market Insights Forecast to 2030

Global HPV18 High Risk with 16 18 Genotyping PCR Test Kit Market Research Report 2024

HPV Genetically Engineered Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pneumococcal Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027

Global Pneumococcal Vaccination Market Research Report 2025

Global Herpes Simplex Virus HSV Vaccines Market Insights Forecast to 2030

Genital Warts Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global HPV Associated Disorder Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions